Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study

Auteurs

Gwénaël Le Teuff, Alicia Castaneda‐Heredia, Christelle Dufour, Timothy Jaspan, Raphael Calmon, Annick Devos, Kieran McHugh, Pierre Leblond, Didier Frappaz, Isabelle Aerts, Christian M. Zwaan, Stéphane Ducassou, Pascal Chastagner, Arnauld Verschuur, Nadège Corradini, Michela Casanova, Hervé Rubie, Riccardo Riccardi, Marie‐Cecile Le Deley, Gilles Vassal, Birgit Geoerger,